General Information of Drug (ID: DM26GBV)

Drug Name
QA1 Drug Info
Synonyms
CHEMBL1210313; GTPL5815; SCHEMBL2407215; BDBM50322839; NCGC00189027-01; NCGC00187765-01; QA1; rac-N-(3-methyl-1-morpholinopentan-3-yl)-N-((1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)methyl)cyclohexanecarboxamide; N-(3-methyl-1-morpholinopentan-3-yl)-N-((1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)methyl)cyclohexanecarboxamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
44156964
TTD Drug ID
DM26GBV

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27788040-Compound-6 DMHX8OF N. A. N. A. Patented [3]
Oxazolo[3,4-a]pyrazine derivative 4 DM1B74D N. A. N. A. Patented [3]
Imidazo pyridine derivative 4 DM3YMHP N. A. N. A. Patented [3]
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 1 DMCISHW N. A. N. A. Patented [3]
Oxazolo[3,4-a]pyrazine derivative 2 DM28E0A N. A. N. A. Patented [3]
Imidazo pyridine derivative 6 DMG6W3O N. A. N. A. Patented [3]
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 3 DMFOBM9 N. A. N. A. Patented [3]
PMID27788040-Compound-6b DMD3U96 N. A. N. A. Patented [3]
Indandione derivative 2 DMVR04K N. A. N. A. Patented [3]
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 4 DM6MCBU N. A. N. A. Patented [3]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuropeptide S receptor (NPSR) TTV1C0Z NPSR1_HUMAN Antagonist [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5815).
2 Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4700-3.
3 Neuropeptide S receptor ligands: a patent review (2005-2016).Expert Opin Ther Pat. 2017 Mar;27(3):347-362.